Drug Report History #3770
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated (Changed) | Updated to: 2017-03-30 | Was: 2017-03-21 |
| Drug Identification Number | 02130955 | 02130955 |
| Brand name | TYPHIM VI | TYPHIM VI |
| Common or Proper name | Salmonella typhi Vi Capsular Polysaccharide Vaccine | Salmonella typhi Vi Capsular Polysaccharide Vaccine |
| Company Name | SANOFI PASTEUR LIMITED | SANOFI PASTEUR LIMITED |
| Ingredients | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE |
| Strength(s) | 25MCG | 25MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size (Changed) | Updated to: 1 x 0.5 mL (single dose) syringe / 1 seringue de 0,5 mL (dose unique) | Was: 1 x 0.5 mL (single dose) syringe |
| Additional packaging sizes | ||
| ATC code | J07AP | J07AP |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2017-03-21 | 2017-03-21 |
| Actual start date | ||
| Estimated end date | 2017-04-15 | 2017-04-15 |
| Actual end date (Changed) | Updated to: 2017-03-29 | Was: |
| Shortage status (Changed) | Updated to: Resolved | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: The shortage has been resolved. | Was: Supply disruptions are anticipated in the private market. |
| Health Canada comments |